Špela Volčanšek

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Insulin Resistance

Systematic Review

Top Venues

Medicina (Kaunas, Lithuania)

Pharmacological reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Michail Kokkorakis, Emir M Muzurović, Špela Volčanšek, Marlene Chakhtoura, Michael A Hill, Dimitri P Mikhailidis, Christos S Mantzoros
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies. Pharmacological reviews 76 (3) (2024)
Michail Kokkorakis, Emir M Muzurović, Špela Volčanšek, Marlene Chakhtoura, Michael A Hill, Dimitri P Mikhailidis, Christos S Mantzoros
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies. Pharmacological reviews 76 (3) (2024)
Ioana-Cristina Bica, Roxana Adriana Stoica, Teodor Salmen, Andrej Janez, Špela Volčanšek, Djordje Popovic, Emir M Muzurović, Manfredi Rizzo, Anca Mihaela Pantea Stoian
The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Ioana-Cristina Bica, Roxana Adriana Stoica, Teodor Salmen, Andrej Janez, Špela Volčanšek, Djordje Popovic, Emir M Muzurović, Manfredi Rizzo, Anca Mihaela Pantea Stoian
The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Ioana-Cristina Bica, Roxana Adriana Stoica, Teodor Salmen, Andrej Janez, Špela Volčanšek, Djordje Popovic, Emir M Muzurović, Manfredi Rizzo, Anca Mihaela Pantea Stoian
The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Špela Volčanšek, Urška Rahne Perc, Mojca Lunder, Drazenka Pongrac Barlovic
No Indices of Increased Type 2 Diabetes Risk in Individuals with Reactive Postprandial Hypoglycemia. Metabolites 12 (12) (2022)
Špela Volčanšek, Urška Rahne Perc, Mojca Lunder, Drazenka Pongrac Barlovic
No Indices of Increased Type 2 Diabetes Risk in Individuals with Reactive Postprandial Hypoglycemia. Metabolites 12 (12) (2022)
Špela Volčanšek, Urška Rahne Perc, Mojca Lunder, Drazenka Pongrac Barlovic
No Indices of Increased Type 2 Diabetes Risk in Individuals with Reactive Postprandial Hypoglycemia. Metabolites 12 (12) (2022)
Špela Volčanšek, Urška Rahne Perc, Mojca Lunder, Drazenka Pongrac Barlovic
No Indices of Increased Type 2 Diabetes Risk in Individuals with Reactive Postprandial Hypoglycemia. Metabolites 12 (12) (2022)